Decline in infectious conjunctivitis during COVID-19 pandemic

Decline in infectious conjunctivitis during COVID-19 pandemic

(HealthDay)—There was a population-wide decrease in the rate of infectious conjunctivitis in association with public health interventions adopted to curb COVID-19, according to a study published online Nov. 18 in JAMA Ophthalmology.

Juan M. Lavista Ferres, from Microsoft Corporation in Redmond, Washington, and colleagues examined whether internet search interest and visits for infectious conjunctivitis were associated with public interventions adopted during COVID-19. Data were compared before and after April 2020, when public health interventions were recommended by the U.S. Centers for Disease Control and Prevention.

The researchers found that from January 2015 to February 2021, there were 1,156 emergency department encounters with a diagnosis of conjunctivitis at a single emergency department. There was a significant, 37.3 percent decrease observed in emergency department encounters for nonallergic conjunctivitis. In contrast, after adjustment for total emergency department encounters, encounters for corneal abrasion and posterior vitreous detachments remained stable. After widespread implementation of to mitigate COVID-19, there was a 34.2 percent decrease in search interest in conjunctivitis.

"Public health initiatives may have contributed to a decline in the number of new infections nationally because there was a relative decrease in emergency department encounters for conjunctivitis during the same period," the authors write. "Search metrics in conjunction with may provide quantifiable metrics of social distancing implementation in the future and a method of surveillance of infectious conjunctivitis."

One author was employed by Microsoft Corporation; a second author disclosed financial ties to the pharmaceutical, , and medical technology industries, as well as Microsoft Corporation.


Explore further

Conjunctivitis prevalence higher for adult women than men

More information: Abstract/Full Text
Editorial
Journal information: JAMA Ophthalmology

Copyright © 2021 HealthDay. All rights reserved.

Citation: Decline in infectious conjunctivitis during COVID-19 pandemic (2021, November 29) retrieved 20 January 2022 from https://medicalxpress.com/news/2021-11-decline-infectious-conjunctivitis-covid-pandemic.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
3 shares

Feedback to editors